Clinical Trial

From Fear to Purpose ACT Protocol. Implications of Death Anxiety in Depression and Anxiety Symptoms.

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 18, 2025 (before its estimated December 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
The main purpose of this placebo controlled trial is to test the efficacy of a one-session From Fear to Purpose ACT intervention in reducing self-reported death anxiety levels. Another objective of this study is to investigate whether reductions in death anxiety levels are associated with reductions in depression and anxiety levels, thus testing if death anxiety is a transdiagnostic factor involved in psychopathology.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-01-31; most recent amendment 2025-04-16.
Trial Details
NCT Number NCT06810999
Lead Sponsor Babes-Bolyai University
Conditions Death Anxiety, Depression, Anxiety
Enrollment 175 participants
Start Date 2025-06-01
Primary Completion 2025-12-30 (estimated)
Study Completion 2025-12-30 (estimated)
Updated on ClinicalTrials.gov 2025-04-18